A 12-week, Randomized, Multicenter, Double-blind, Active-controlled, Non-inferiority Study to Compare the Efficacy and Safety of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients
This is a 12-week, randomized, multicenter, double-blind, active-controlled, non-inferiority study (TATPITA20101005) to compare the efficacy and safety of pitavastatin (Livalo®) and atorvastatin (Lipitor®) in high risk hypercholesterolemic patients.
100 Clinical Results associated with Tai Tien Pharmaceuticals Co., Ltd.
0 Patents (Medical) associated with Tai Tien Pharmaceuticals Co., Ltd.
100 Deals associated with Tai Tien Pharmaceuticals Co., Ltd.
100 Translational Medicine associated with Tai Tien Pharmaceuticals Co., Ltd.